Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B marketing, and business software for healthcare and insurance professionals worldwide. More Details
Good value with proven track record.
Share Price & News
How has Cegedim's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: Insufficient data to determine CGMP's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine CGMP's volatility change over the past year.
7 Day Return
GB Healthcare Services
1 Year Return
GB Healthcare Services
Return vs Industry: CGMP underperformed the UK Healthcare Services industry which returned 75.8% over the past year.
Return vs Market: CGMP underperformed the UK Market which returned 26.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Cegedim's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Cegedim undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CGMP (€23.98) is trading below our estimate of fair value (€30.72)
Significantly Below Fair Value: CGMP is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CGMP is good value based on its PE Ratio (32.3x) compared to the XE Healthcare Services industry average (45.9x).
PE vs Market: CGMP is poor value based on its PE Ratio (32.3x) compared to the UK market (26.1x).
Price to Earnings Growth Ratio
PEG Ratio: CGMP is poor value based on its PEG Ratio (1.2x)
Price to Book Ratio
PB vs Industry: CGMP is good value based on its PB Ratio (1.7x) compared to the GB Healthcare Services industry average (6.6x).
How is Cegedim forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CGMP's forecast earnings growth (26.2% per year) is above the savings rate (0.9%).
Earnings vs Market: CGMP's earnings (26.2% per year) are forecast to grow faster than the UK market (17.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CGMP's revenue (3.3% per year) is forecast to grow slower than the UK market (5.3% per year).
High Growth Revenue: CGMP's revenue (3.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CGMP's Return on Equity is forecast to be low in 3 years time (9.7%).
How has Cegedim performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CGMP has a large one-off loss of €26.1M impacting its December 31 2020 financial results.
Growing Profit Margin: CGMP's current net profit margins (2.2%) are higher than last year (0.5%).
Past Earnings Growth Analysis
Earnings Trend: CGMP has become profitable over the past 5 years, growing earnings by 14% per year.
Accelerating Growth: CGMP's earnings growth over the past year (297.3%) exceeds its 5-year average (14% per year).
Earnings vs Industry: CGMP earnings growth over the past year (297.3%) exceeded the Healthcare Services industry 8.6%.
Return on Equity
High ROE: CGMP's Return on Equity (5.3%) is considered low.
How is Cegedim's financial position?
Financial Position Analysis
Short Term Liabilities: CGMP's short term assets (€370.5M) do not cover its short term liabilities (€403.3M).
Long Term Liabilities: CGMP's short term assets (€370.5M) exceed its long term liabilities (€294.1M).
Debt to Equity History and Analysis
Debt Level: CGMP's debt to equity ratio (90.9%) is considered high.
Reducing Debt: CGMP's debt to equity ratio has reduced from 175.4% to 90.9% over the past 5 years.
Debt Coverage: CGMP's debt is well covered by operating cash flow (58.4%).
Interest Coverage: CGMP's interest payments on its debt are well covered by EBIT (5.4x coverage).
What is Cegedim current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CGMP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CGMP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CGMP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CGMP's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: CGMP is not paying a notable dividend for the UK market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CGMP's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Jean-Claude Labrune has been the Chief Executive Officer of Cegedim SA since August 18, 1994. Mr. Labrune serves as President of S.A.S. He founded Cegedim SA in 1969 and served as its Managing Director...
CEO Compensation Analysis
Compensation vs Market: Jean-Claude's total compensation ($USD655.73K) is about average for companies of similar size in the UK market ($USD718.45K).
Compensation vs Earnings: Jean-Claude's compensation has been consistent with company performance over the past year.
Experienced Management: CGMP's management team is seasoned and experienced (15.2 years average tenure).
Experienced Board: CGMP's board of directors are considered experienced (4.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cegedim SA's company bio, employee growth, exchange listings and data sources
- Name: Cegedim SA
- Ticker: CGMP
- Exchange: BATS-CHIXE
- Founded: 1969
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: €349.032m
- Shares outstanding: 13.80m
- Website: https://www.cegedim.fr
Number of Employees
- Cegedim SA
- 137 rue d'Aguesseau
Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B marketing, and business software for healthcare and insurance professionals wor...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/09 01:09|
|End of Day Share Price||2021/04/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.